Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.

Brainomix scientists analysing brain scan

It’s no coincidence that the best-known acronym for spotting signs of a stroke urges FAST action. Every second counts, not least for the clinicians making crucial decisions about diagnosis and treatment.

Brainomix is a digital health company which spun out of the University’s preclinical stroke lab, part of the Nuffield Department of Clinical Neurosciences, in 2010. It was co-founded by Dr Michalis Papadakis, who now works full-time as the company's CEO.

The company has developed state-of-the-art AI algorithms to help doctors make quick, accurate decisions for patients. Its e-Stroke platform analyses images from simple CT scans, providing detailed real-time information – available to view remotely – on the extent and nature of damage to the brain.

Read the full story on the University of Oxford website